EDBI

Type

Venture Capital

Status

Active

Location

Singapore, Singapore

Total investments

182

Average round size

69M

Portfolio companies

131

Rounds per year

5.52

Lead investments

23

Follow on index

0.27

Exits

33

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareEnterprise SoftwareMedicalPharmaceuticalTherapeutics

Summary

EDBI appeared to be the VC, which was created in 1991.

The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Bitmain Technologies, Moderna Therapeutics, Magic Leap We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the EDBI, startups are often financed by Sequoia Capital India, Qualcomm Ventures, Accel. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Intel Capital, Sequoia Capital India. In the next rounds fund is usually obtained by New Enterprise Associates, Delphi Ventures, West Health Investment Fund.

Besides them, we counted 16 critical employees of this fund in our database.

Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. When the investment is from EDBI the average startup value is more than 1 billion dollars. This EDBI works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2018.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistHealthcareManufacturingFintechClimate tech
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
SGD 285000000
Fund raised date
2021-07-28

Analytics

Total investments
182
Lead investments
23
Exits
33
Rounds per year
5.52
Follow on index
0.27
Investments by industry
  • Biotechnology (62)
  • Health Care (48)
  • Software (39)
  • Artificial Intelligence (20)
  • Pharmaceutical (18)
  • Show 192 more
Investments by region
  • United States (105)
  • Singapore (54)
  • China (5)
  • Philippines (2)
  • Liechtenstein (1)
  • Show 9 more
Peak activity year
2021
Number of Unicorns
20
Number of Decacorns
21
Number of Minotaurs
10

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
657M
Group Appearance index
0.96
Avg. company exit year
10
Avg. multiplicator
11.17
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Doctor Anywhere 21 Dec 2022 Information Technology, Health Care, Hospital, Unified Communications Late Stage Venture 38M Central, Singapore, Singapore
Leo Cancer Care 11 Jun 2024 Health Care Late Stage Venture England, Surrey, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.